Home » Press Releases

Press Releases

mdgroup and Illingworth Research Group form strategic partnership to provide patients the ability to choose where their clinical trial visits take place

March 9th 2017

mdgroup, through its patientprimary service, has partnered with Illingworth Research Group, to offer our clients an enhanced, a truly patient-centric service.

Studies have found minimising trips to hospitals, while maintaining a high level of involvement, can be a crucial element to patient recruitment and retention levels, which could ultimately save pharmaceutical and biotech companies millions. This can also have a positive impact on other areas of the study, as allowing patients the choice to have visits performed at home or in the workplace or hybrid solutions reduces the burden on sites.

Please click here to read the full press release

 

Illingworth Research Group Limited Strengthens Business Development and Marketing Functions

February 10th 2017

Illingworth Research Group are happy to announce the appointment of Richard Smith, Director of Business Development and Amy Bumford, Business Development & Marketing Associate.

Richard joins Illingworth after a multifaceted and successful career in business development across a variety of sectors. Richard will further strengthen the Business Development in liaising with present and potential clients. Amy Bumford joins the company with knowledge of a diverse range of marketing communications. Amy has a wealth of experience within digital marketing and database management which made her the ideal candidate to support both the IT and Business Development functions.

Please click here to read the full press release

 

Illingworth Research Group Limited Launch Major Rebrand

February 9th 2017

UK based CRO, Illingworth Research Group Limited, has undergone a total brand review and is delighted to unveil its new logo, website and updated corporate collateral to support its expansion.

Commenting on the rebrand, CEO, John Illingworth says “The new brand identity brings ResearchNurses.co, our on and off-site research nursing service under the Illingworth Research Group Limited umbrella alongside our CRO and medical photography services for clinical trials. It is important that Illingworth retains its established values of flexible, high-quality clinical trial provision, whilst developing a new and modern identity. The new logo represents the 3 branches of the company and offers a more contemporary look and feel, which will provide longevity as we continue to evolve and expand.”

Please click here to read the full press release

 

Illingworth Research & ResearchNurses.co Leading Afferent Chronic Cough Study In The UK

October 5th 2016

A new drug which could offer relief to those affected by chronic cough is now being tested by the NIHR Translational Research Partnership (TRP) as part of a twelve week clinical trial. The drug, called AF-219, is being developed by US based biotech company, Afferent Pharmaceuticals. The trial involves 200 patients at 47 sites in the UK and US. Working with the NIHR, Illingworth Research  are managing the UK study sites for this trial on behalf of Afferent with ResearchNurses.co providing Research Nursing support services.

You can read the full press release here

 

Illingworth Research & ResearchNurses.co Adds Vice President,  Strategic Development

October 5th 2016

Illingworth Research & ResearchNurses.co, a specialist Clinical Research Organization to the biopharmaceutical and medical device industries offering medical photography, home care research nursing and CRO services, is pleased to welcome Helen Springford to it’s management team as Vice President, Strategic Development.

Helen was appointed Vice President, Strategic Development at Illingworth Research in August 2016 and comes to us with over 25 years’ experience in the Clinical Trials arena. Helen graduated with an honours degree in Nursing Sciences in 1990 and started her clinical trials career as a research nurse in London. Since then, she  has managed an SMO and held various positions in both CROs and big pharma within several functional areas including Clinical Operations, Project Management, Business Development and Proposals.

Within this new role Helen is responsible for Business Development, Strategic Partnerships and Executive Oversight.

“We are very excited about having Helen join us,” said John Illingworth, Managing Director of Illingworth Research and ResearchNurses.Co. John Illingworth added, “Helen will play a significant role in helping expand our business by increasing sales and marketing activities as well as provide additional Operational Executive Oversight. Helen will use her experience and background to help us get to the next stage in our development.

For more information about Illingworth Research, contact Helen.Springford@illingworthresearch.com

 

Please click on the links below for pdf copies of our past press releases:

Illingworth Research – New Service Medical Photography Press Release 2011 10 07

Illingworth Research – Highland Marketing Press Release 2011 08 25

Illingworth Research – Company Launch Press Release 2011 06 01

MultiCell Technologies – Illingworth Research Press Release 2010 06 14